Kota Ouchi, Eiji Shinozaki, Ken Shimada, Shin Takahashi, Kiichi Sugimoto, Hiroshi Matsumoto, Kenji Amagai, Takeshi Suto, Yasuhiro Sakamoto, Akira Okita, Kazunori Otsuka, Naoya Akazawa, Taichi Isobe, Koji Fukuda, Hideki Shimodaira, Yoshiaki Shindo, Mizunori Yaegashi, Hisato Kawakami, Chikashi Ishioka. "T-CORE2401 trial: A randomized phase II trial of mFOLFOX6 plus cetuximab versus mFOLFOX6 plus bevacizumab as first-line treatment for right-sided,
                    <i>RAS</i>
                    /
                    <i>BRAF</i>
                    wild-type, low-methylated metastatic colon cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps280